Ki-ras point mutations and proliferation activity in biliary tract carcinomas

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 930-935

  Ohashi, K ^a   Tsutsumi, M ^a   Nakajima, Y ^a   Nakano, H ^a   Konishi, Y ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Biliary tract carcinoma; Cholangiocarcinogenesis; Ki ras gene; Polymerase chain reaction single strand conformation polymorphism; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE;

ARTICLE; BILE DUCT CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; EXON; GALLBLADDER CARCINOMA; GENE FREQUENCY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0029763279     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.459     Document Type: Article

References (42)

1. ALMOGUERA C, SHIBATA D, KORRESTER K, MARTIN J, ARNHEIM N AND PERUCHO M. (1988). Most human carcinomas of the exocrine pancreas contain mutant c-K-ras gene. Cell, 53, 549-554.
2. BOERMA EJ. (1990). Research into the results of resection of hilar hile duct cancer. Surgery , 108, 572-580.
3. BRAVO R, FRANK R, BLUNDELL PA AND BRAVO HM. (1987). Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature, 326, 515-517.
4. BURMER GC AND LOEB LA. (1989). Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc. Natl Acad. Sci. USA, 86, 2403-2407.
5. CAPELLA G, CRONAUER-MITRA S, PEINADO MA AND PERUCHO M. (1991). Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ. Health Perspect., 93, 125-131.
6. CERNY WL, MANGOLD KA AND SCARPEELI DG. (1992). K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res., 52, 4507-4513.
7. FEARON ER AND VOGELSTEIN B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
8. FORRESTER K, ALMOGUERA C, HAN K, GRIZZLE WE AND PERUCHO M. (1987). Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature, 327, 298-303.
9. FUJIWARA T, GRIMM EA, MUKHOPADHAY T, ZHANG WW, OWENSCHAUB LB AND ROTH JA. (1994). Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type ras gene. Cancer Res. 54, 2287-2291.
10. GYLLENSTEN UB AND ERLICH HA. (1988). Generation of single-strand DNA by the polymerase chain reaction and its application to direct sequencing of the HLA DQA locus. Proc. Natl Acad. Sci. USA, 85, 7652-7656.
11. HSU SM, RAINE L AND RANGER H. (1981). Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580.
12. IMAI M, HOSHI T AND OGAWA K. (1994). K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer, 73, 2723-2733.
13. KITAMOTO M, NAKANISHI T, KIRA S, KAWAGUCHI N, NAKASHIRO R, SUEMORI S, KAJIYAMA G, ASAHARA T AND DOHI K. (1993). The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer, 72, 1859-1865.
14. KOKKINAKIS DM AND SCARPELLI DG. (1989). DNA alkylation in the hamster induced by two pancreatic carcinogens. Cancer Res., 49, 3184-3189.
15. KOMI N, TAKEHARA H AND KUNITOMO K. (1989). Choledochal cyst: anomalous arrangement of the pancreaticobiliary ductal system and biliary malignancy. J. Gastroenterol. Hepatol., 4, 63-74.
16. KRZYZOIAK WJ, SHINDO-OKADA N, TESHIMA H, NAKAJIMA K AND NISHIMURA S. (1992). Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine. Proc. Natl Acad. Sci. USA, 89, 4879-4883.
17. LAWSON TA, GINGELL R, NAGEL D, HINES LA AND ROSS A. (1981). Methylation of hamster DNA by the carcinogen N-nitrosobis-(2-oxopropyl)amine. Cancer Lett., 11, 251-255.
18. LEVI S, URBANO-ISPIZUSA A, THOMAS DM, GILBERTSON J, FOSTER C AND MARSHALL CJ. (1991). Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res. 51, 3497-3502.
19. MAKINO T AND KONISHI Y. (1985). Hyperplasia, adenoma, gall bladder, hamster. In Monographs on Pathology of Laboratory Animals: Digestive System. Jones TC, Mohr U and Hunt RD (eds) pp. 79-82. Springer-Verlag: Berlin, Heidelberg, New York, Tokyo.
20. MARIYAMA M, KISHI K, NAKAMURA K, OBATA H AND NISHIMURA S. (1989). Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn. J. Cancer Res., 80, 622-626.
21. MARX J. (1989). Research news: many gene changes found in cancer. Science, 246, 1386-1388.
22. MOTOJIMA K, TSUNODA T, KANEMATSU T, NAGATA Y, URANO T AND SHIKU H. (1991). Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann. Surg., 214, 657-662.
23. OHASHI K, TSUTSUMI M, NAKAJIMA Y, NOGUCHI O, OKITA S, KITADA S, TSUJIUCHI T, KOBAYASHI K, NAKANO H AND KONISHI Y. (1994b). High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas. Jpn. J. Clin. Oncl., 24, 305-310.
24. OHASHI K, NAKAJIMA Y, TSUTSUMI M, KANEHIRO H, FUKUOKA T, HISANAGA M, TAKI J, NAKAE D, KONSHI Y AND NAKANO H. (1994a). Clinical characteristics and proliferating activity of intrahepatic cholangiocarcinoma. J. Gastroenterol, Hepalol., 9, 442-446.
25. OHASHI K, NAKAJIMA Y, KANEHIRO H, TSUTSUMI M, TAKI J, AOMATSU Y, YOSHIMURA A, KOS, KIN T, YAGURA K, KONISHI Y AND NAKANO H. (1995). Ki-ras and p53 protein expression in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastronenterology, 109, 1612-1617.
26. OHTA H, YAMAGUCHI Y, YAMAKAWA O, WATANABE H, SATOMUTA Y, MOTOO Y, OKAI T, TERADA T AND SAWABU N. (1993). Biliary papillomatosis with the point mutation of K-ras gene arising in congenital choledochal cyst. Gastroenterology, 105, 1209-1212.
27. OKUDA K, KUBA Y, OKAZAKI N, ARISHIMA T, HASHIMOTO M, JINNOUCHI S, SAWA Y, SHIMOKAWA Y, NAKAJIMA Y, NOGUCHI T, NAKANO M, KOJIRO M AND NAKASHIMA T. (19877). Clinical aspects of intrahepatic hile duct carcinoma including hilar carcinoma. A study of 57 autopsy-proven cases. Cancer, 39, 232-246.
28. ORITA M, SUZUKI Y, SEKIYA T AND HAYASHI K. (1989). Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879.
29. QIAN D, KINOCHI T, KUNITOMO K, KATAOKA K, MATIN MA, AKIMOTI S, KOMI N AND OHNISHI Y. (1993). Mutagenicity of the bile of dogs with an experimental model of an anomalous arrangement of the pancreaticobiliary duct. Carcinogenesis, 14, 743-747.
30. SANGER F, NICKLEN S AND COULSON AR. (1992). DNA sequencing with chain-terminating inhibitors. Biotechnology, 24, 104-108.
31. SCARPA A, CAPELLI P, VILLANEUVA A, ZAMBONI G, LLUIS F, ACCOLLA R, MARIUZZI G AND CAPELLA G. (1994). Pancreatic cancer in Europe: Ki-ras gene mutation pattern shows geographical differencies. Int. J. Cancer, 57, 167-171.
32. SHIRASAWA S, FURUSE M, YOKOYAMA N AND SASAZUKI T. (1993). Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science, 260, 85-88.
33. STORK P, LODA M, BOSARI S, WIELY B, POPPENHUSEN K AND WOLFE H. (1991). Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene, 6, 857-862.
34. SUMI S, BEAUCHAMP RD, TOWNSEND CM, UCHIDA Jr T, MURAKAMI M, RAJARMAN S, ISHIZUKA J AND THOMPSON JC. (1992). Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology, 103, 982-989.
35. SUZUKI Y, SEKIYA TA AND HAYASHI K. (1991). Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single strand component among a mixture of sequence variants. Anal. Biochem., 192, 82-84.
36. TADA M, YOKOSUKA O, OMATA M, OHTO M AND ISONO K. (1990). Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer, 66, 930-935.
37. TRAHEY M AND McCORMIK F. (1987). A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not effect oncogenic mutants. Science, 238, 542-545.
38. TSUDA H, SATARUG S, BHUDHISAWASDI Y, KIHANA T, SUGIMURA T AND HIROHASHI S. (1993). Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene. Mol. Carcinogenesis, 6, 266-269.
39. TSUTSUMI M, MURAKAMI Y, KONDOH S, TSUJIUCHI T, HOHNOKI K, HORIGUCHI K, NOGUCHI O, KOBAYASHI E, OKITA S, SEKITA T AND KONISHI Y. (1993a). Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine. Jpn. J. Cancer Res., 84, 956-960.
40. TSUTSUMI M, KONDOH S, NOGUCHI O, HORIGUCHI K, KOBAYASHI E, OKITA S, OHASHI K, HONOKI K, TSUJIUCHI T AND KONISHI Y. (1993b). K-ras gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters. Jpn. J. Cancer. Res., 84, 1101-1105.
41. WRIGHT DK AND MANOS MM. (1990). Sample preparation from paraffin-embedded tissues. In PCR Protocols, Innes MA, Gelfand DH, Sninsky JJ and White TJ. (eds) pp. 153-158. Academic Press: San Diego.
42. YANAGISAWA A, OHTAKE K, OHASHI K, HORI M, KITAGAWA M, SUGANO H AND KATO Y. (1993). Frequent c-Li-ras oncogene activation in mucous cell hyperplasia of pancrease suffering from chronic inflammation. Cancer Res., 53, 953-956.